BIOMAT Database Logo BIOMAT Database Logo

[Evaluation of the objective efficacy of mepartricin in benign prostatic hypertrophy]. 1988

E Cirillo Marucco, and G Giocoli Nacci, and A Pagliarulo, and G Balacco, and G Ludovico

UI MeSH Term Description Entries
D008297 Male Males
D008613 Mepartricin Polyene macrolide antibiotic with unknown composition. It is obtained from Streptomyces aureofaciens. It is used as an antifungal agent, an antiprotozoal agent, and in the treatment of BENIGN PROSTATIC HYPERTROPHY. Methylpartricin,Mepartricin A,Mepartricin B,Methyl Partricin,SPA-S 160,Tricandil,SPA S 160,SPAS 160
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011090 Polyenes Hydrocarbons with more than one double bond. They are a reduced form of POLYYNES. Cumulenes
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D014555 Urination Disorders Abnormalities in the process of URINE voiding, including bladder control, frequency of URINATION, as well as the volume and composition of URINE. Disorder, Urination,Disorders, Urination,Urination Disorder

Related Publications

E Cirillo Marucco, and G Giocoli Nacci, and A Pagliarulo, and G Balacco, and G Ludovico
[Clinical evaluation of mepartricin in benign prostatic hypertrophy].
January 1988, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
E Cirillo Marucco, and G Giocoli Nacci, and A Pagliarulo, and G Balacco, and G Ludovico
[Mepartricin as medical treatment of benign prostatic hypertrophy].
January 1993, Journal d'urologie,
E Cirillo Marucco, and G Giocoli Nacci, and A Pagliarulo, and G Balacco, and G Ludovico
Objective noninvasive evaluation of benign prostatic hypertrophy.
January 1995, Biomedical instrumentation & technology,
E Cirillo Marucco, and G Giocoli Nacci, and A Pagliarulo, and G Balacco, and G Ludovico
[Treatment of benign prostatic hypertrophy using mepartricin at high dosage].
January 1988, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
E Cirillo Marucco, and G Giocoli Nacci, and A Pagliarulo, and G Balacco, and G Ludovico
[Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy].
January 1988, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
E Cirillo Marucco, and G Giocoli Nacci, and A Pagliarulo, and G Balacco, and G Ludovico
[Therapeutic efficacy of mepartricin in the medical treatment of prostatic hypertrophy].
May 1986, Minerva medica,
E Cirillo Marucco, and G Giocoli Nacci, and A Pagliarulo, and G Balacco, and G Ludovico
[Use of mepartricin in the treatment of benign prostatic hypertrophy. Evaluation of clinical and functional parameters].
January 1988, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
E Cirillo Marucco, and G Giocoli Nacci, and A Pagliarulo, and G Balacco, and G Ludovico
[Double-blind evaluation of mepartricin 150.000 U (40 mg) compared with placebo in benign prostatic hypertrophy].
December 1996, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
E Cirillo Marucco, and G Giocoli Nacci, and A Pagliarulo, and G Balacco, and G Ludovico
[Role of mepartricin in patients with benign prostatic hypertrophy. Study of 24 patients].
January 1987, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
E Cirillo Marucco, and G Giocoli Nacci, and A Pagliarulo, and G Balacco, and G Ludovico
[Mepartricin in the treatment of benign prostatic hyperplasia].
January 1988, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
Copied contents to your clipboard!